Autopsy report · NCT01474200

Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment

“Closed due to patient recruitment challenges. No interim analyses were completed; study closure was not related to any concerns about safety or futility.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 224 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Nuwellis, Inc.

Sponsor type

Industry

Conditions

Heart Failure; Cardiac Failure; Acute Decompensated Heart Failure (ADHF)

Interventions

Isolated veno-venous ultrafiltration (AQ); IV Loop Diuretics (LD)

Participants

224

Sites

38

Countries

United States

Trials that died the same way

• Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer
  “This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.” (78% match in meaning)
• Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
  “This study was closed to enrollment as of 13 May 2011 due to business reasons. Premature closure was not prompted by any safety or efficacy concerns.” (76% match in meaning)
• Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement
  “Study was closed due to lack of personnel for recruitment/enrollment purposes.” (75% match in meaning)
• Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
  “Study closed due to lack of patient enrollment.” (75% match in meaning)
• Triple vs High Dose Inhaled CORticosteroids
  “The study is closed due to lack of recruitment.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.